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Characterization of Gene Expression Profiles of Normal Canine Retina
and Brain Using a Retinal cDNA Microarray
Abstract
Purpose: Construction of a canine retinal custom cDNA microarray for comprehensive retinal gene
expression profiling and application for the identification of genes that are preferentially expressed in the
retina and brain lobes using a brain pool reference tissue.
Methods: A cDNA microarray was constructed utilizing clones obtained from a normalized canine retinal
expressed sequence tag library. Gene expression profiles were analyzed for normal retina, as well as the cortex
of the frontal, occipital, and temporal brain regions. Each sample was studied against a reference sample of
pooled brain RNA. Data from a quantified scanned image were normalized using the loess subgrid procedure.
Retina-enriched genes were identified using the Significance Analysis of Microarrays (SAM) algorithm, and
confirmed by northern blot analyses for selected genes. Differences between biological samples were
displayed using principal component analysis (PCA).
Results: Expression profiles for each tissue set were analyzed against the common reference of pooled brain.
Changes in expression between the sample and the reference were higher in the retina (27.9%) than the
individual brain tissues (2-6.6%). Furthermore, all individual retinal samples were clearly separated from any
of the hybridizations using brain tissue in the PCA. The accuracy of observed changes in expression has been
confirmed by northern blot analysis using five randomly chosen genes that represented a wide range of
different expression levels between retina and brain.
Conclusions: We have established an accurate and robust microarray system suitable for the investigation of
expression patterns in the retina and brain. Characterization of the gene expression profiles in normal retina
will facilitate the understanding of the processes that underline differences between normal and diseased
retinas.
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 The domesticated dog, Canis familiaris, exhibits a di-
verse repertoire of morphological and behavioral characteris-
tics that define the numerous specific breeds. This segrega-
tion, in effect the creation of genetic isolates, has resulted in
the emergence of autosomal recessive inherited canine dis-
eases that are often directly comparable to those observed in
humans. Many of these affect the retina and result in a large
group of genotypically distinct retinal disorders representing
molecular and phenotypic counterparts in humans. By far the
largest group of diseases in dog, termed progressive retinal
atrophy (PRA), serve as disease homologs for retinitis
pigmentosa (RP) in humans [1]. Although the final common
pathway of photoreceptor degeneration in many retinal de-
generative processes appears to be apoptosis [2-4], it is likely
that differing mechanisms link the causative mutations to the
cell death processes. Insights into these mechanisms are criti-
cal to develop therapeutic strategies, and these studies are de-
pendent on animal models. One approach to examine the path-
ways involved in retinal degenerative diseases in animal mod-
els is gene expression profile analysis with the aim of identi-
fying early alterations in gene expression that contribute to
photoreceptor cell death [5]. The microarray technology shows
potential as a useful tool to identify genes and gene pathways
involved in ocular disease progression and may therefore aid
in the characterization and classification of these diseases,
possibly identifying a common mechanism linking disorders
into groups [6,7].
Microarrays have been useful in the simultaneous analy-
sis of transcript levels of thousands of genes in different physi-
ological states of an organism, tissue, or cell [8,9]. Construc-
tion of microarrays is most efficient when information is uti-
lized from annotated genomes or expressed sequence tags
(ESTs) and has led to new insights into animal development,
cancer, infectious diseases, and aging [10-12]. A major limi-
tation of the technique is the analysis of sequences represented
on the array. This disadvantage is particularly problematic
when analyzing highly specialized tissues such as the retina
due to the repertoire of uniquely or preferentially expressed
genes contributing to its structure and function. In the case of
“orphan” species, commercial arrays are either not available
or targeted to a broader research community and
underrepresent the tissue of interest. The current available
canine microarray is based on transcripts representing 11
nonretina tissues and gene predictions not supported by ex-
perimental data (Affymetrix Genechip® Canine Genome Ar-
ray, Santa Clara, CA). To obtain insight into intrinsic processes
of the canine and human retina, great efforts are directed to-
ward the identification and characterization of transcripts with
functional relevance to this tissue [13-15]. Despite these ad-
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vances, a remaining challenge is to obtain an expression map
of the canine retina/retinal pigmented epithelium
transcriptome, further facilitating the identification of retinal
susceptibility genes but, most importantly, offering an invalu-
able resource for functional genomics studies.
To overcome these limitations and drive the development
of the canine retina transcriptome, we selected about 4,500
genes from a normalized canine retinal EST database [16].
These were used to construct a canine retinal cDNA microarray
for expression profiling of genes that are of interest in studies
of normal development and function and pathological condi-
tions of the retina. As the brain and retina have a common
embryological origin, a brain pool was initially validated as a
reference sample for comparing expression profiles in mul-
tiple samples from animals with different molecularly defined
retinal diseases and at different stages of the disorders. As part
of this study, we have compared gene expression profiles be-
tween normal retina and different regions of the brain cortex
(frontal, occipital, temporal) to identify those genes preferen-
tially expressed in either tissue. The overall aim of this study
is the identification of retina specific gene expression patterns
that will maximize the use in a variety of PRA dog models
[1].
METHODS
Tissue collection and RNA preparation:  Retinas and brain
samples were collected from three 16-week-old normal beagles
(two males and one female) that were part of a specific-patho-
gen-free (SPF) colony at Cornell University. In addition, reti-
nas and spleen samples were obtained from two 16-week-old
crossbred dogs (one male and one female) that were part of
NEI/NIH sponsored projects (R01EY06855, R01EY13132)
and were kept at the Retinal Disease Studies Facility (RDSF)
in Kennett Square, PA. All dogs were housed in an indoor
kennel under 12 h cyclic light conditions, and eyes were col-
lected at a single time period (noon) to avoid potential fluc-
tuations in retinal gene expression with time of day [17-22].
Both eyes were enucleated from the light-adapted dogs fol-
lowing intravenous anesthesia with sodium pentobarbital, and
the dogs were euthanized after enucleation with an overdose
of the barbiturate. The retinas were collected within 1-2 min
after enucleation, and brain and spleen samples obtained within
5-10 min after euthanasia; all tissues were flash frozen in liq-
uid nitrogen and stored at -80 °C until use. The research was
conducted in full compliance with the ARVO Resolution on
the Use of Animals in Research.
RNA isolation:  Total RNA was isolated using Trizol re-
agent (Invitrogen, Carlsbad, CA) and further purified by
RNeasy mini kit (Qiagen, Valencia, CA). Purity and RNA
quality were evaluated by absorbance at 260 nm and by dena-
turing formaldehyde agarose gel electrophoresis. High qual-
ity RNAs with A260/A280 ratio over 1.8 and intact 28S and 18S
RNA bands were used for microarray analysis. To generate an
RNA reference sample for microarray hybridizations, we
pooled equal amounts of total RNA from the cortex of the
occipital, temporal, and frontal brain regions collected from
three 16-week-old beagles to achieve a homogeneous pool of
transcripts. The pooled RNA was divided into aliquots (2 µg/
µl) and stored at -80 °C until use. For the purpose of this work,
four tissue groups have been established, containing five bio-
logical replicates for normal retina and three for each respec-
tive brain region. After initial validation of reproducibility,
only one microarray experiment was used for each sample.
Microarray construction:  For microarray production,
3,931 “UniGene” sequences are represented by individual
clones from a canine retinal EST library [16]; another 120
unique sequences were added by two clones each to ensure
complete coverage of cDNA. In addition, about 300 genes
resulting from retinal subtraction libraries [16] or serving as
controls were printed on the microarray. Each clone was picked
from glycerol stocks manually, inoculated in 50 µl of LB Broth
Base (Invitrogen) with 100 µg/ml ampicillin and grown over-
night at 37 °C. PCR was performed in two 15 µl reactions for
each clone by dipping the template into a master mix (1.5 µM
MgCl2, 0.2 µM dNTP, 0.4 µM of each primer [T7: 5'-TAA
TAC GAC TCA CTA TAG GG-3'; Sp6: 5'-ATT TAG GTG
ACA CTA TAG-3'] and 1 U Taq polymerase) with a replicator,
and amplified for 40 cycles at 94 °C for 10 s, 54 °C for 20 s
and 72 °C for 1 min, after an initial denaturing step at 95 °C
for 1 min, and followed by a final extension at 72 °C for 10
min. PCR products for each clone were pooled and purified
using Millipore Montage PCR384 Filter Plates (Millipore,
Billerica, MA). PCR products were resuspended in 50 µl of
distilled water, and 6 µl were run on a 1% agarose gel. Rhodop-
sin, (RHO), and β-Actin (ACTB) were used as positive con-
trols, while microsatellite locus CUX20001 [23] was used as
a genomic control spot. All PCR products plus Array Con-
trol™ PCR Spots (Ambion, Austin, TX; spots 1-8) were spot-
ted on Telechem superamine glass slides (TeleChem Interna-
tional, Inc., Sunnyvale, CA) using a Cartesian Pysix 5000
printer.
Microarray hybridization and scanning:  Ten µg of pooled
canine brain total RNA was hybridized against 10 µg of the
respective test sample. Tissues were fluorescent-labeled us-
ing an indirect labeling protocol (3 DNA Array Kit,
Genesphere, Inc. Hatfield, PA) following the manufacturer’s
protocol. Hybridization signals were visualized with Cy5 and
Cy3 fluorescent reporter molecules, and intensities were de-
tected using a GenePix 4000B Scanner (Molecular Devices
Corporation, Union City, CA). Scanned images were processed
using GenePix Pro version 6.0 (Molecular Devices Corpora-
tion, Downington, PA). The main quantities of interest pro-
duced by the image analysis (segmentation and background
correction) are the (R, G) fluorescence intensity pairs for each
gene on each array (R=red for Cy5, and G=green for Cy3).
Loess (locally weighted regression) normalization was per-
formed to remove systematic variation that occurs in every
microarray experiment. An MA plot was used to represent the
(R, G) data, where M=log2 (R/G) and A=log2(RG) [24]. For
complete consideration surrounding the normalization process,
loess normalization over the entire chip, and block-specific
loess normalization followed by additional scaling via maxi-
mum likelihood estimation (MLE) or median absolute devia-
tion (MAD) were also studied.
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Statistical analysis:  Each hybridization was annotated
according to MIAME (Minimal Information About a
Microarray Experiment) standards, and analyzed with
GeneSpring version 7.2 (Silicon Genetics, Agilent Technolo-
gies, Palo Alto, CA; GPL3951, GPL3957, and GSE5208).
Controls were used for quality control and normalization of
the microarrays using GeneSpring, but ignored for the statis-
tical data analysis. Significant changes in expression were iden-
tified with Significance Analysis of Microarrays (SAM, 1.15,
Stanford University, Palo Alto, CA) [25] at a delta value re-
sulting in a false discovery rate (FDR) of less than 10%. Only
statistically significant changes will be reported here; how-
ever, the entire dataset is available from the authors on re-
quest.
Principal component analysis (PCA) was performed on a
complete microarray dataset consisting of log-transformed ex-
pression values for each individual replicate. As a result, the
dimensionality of the dataset was reduced and described in a
series of axes that explain the variance within the data. In this
analysis, 30.4%, 16.98%, and 14.1% of the variance within
the data was accounted for by the X, Y, and Z axes, respec-
tively. These were used to plot the data and give an impres-
sion of the variation between the individual datasets; distances
between points on the graph are indicative of the differences
between replicates.
Northern analysis:  Northern analysis was used to con-
firm expression patterns observed in the microarray data. To-
tal RNA (10 µg) from brain (equal representation of frontal,
temporal, and occipital cortex regions), retina and spleen were
separated on a 1% formaldehyde-agarose gel and transferred
to a membrane (GeneScreen Plus Hybridization Transfer Mem-
brane, Perkin Elmer Life Sciences, Inc. Boston, MA). The RNA
was crosslinked to the membrane and hybridized to purified
cDNA probes labeled with [α32P] dCTP using a DNA-label-
ing system (RadPrime DNA Labeling System, Invitrogen) at
68 °C overnight using ExpressHyb Solution (Clonetech, Palo
Alto, CA), and washed in 2X SSC, 0.05% SDS, and 0.1%
SSC, 0.05% SDS for 40 min each.
Probes for northern analysis were obtained by RT-PCR
with primers designed from the corresponding cDNA clone
information [16] (Appendix 1). For RT-PCR, 0.5 µg of total
RNA was incubated in a reaction mixture containing primer
(50 µM oligo(dT) 20, or 50 ng/µl random primer), 10 µM of
dNTPs mix, 40 U/µl of RNase inhibitor, ThermoScript™ RT
(15 U/µl; Invitrogen), 25 mM of MgCl2 10X cDNA synthesis
buffer in a final volume of 25 µl. The samples were incubated
at 70 °C for 5 min to denature the RNA then put on ice and
amplified as follows: 94 °C, 1 min; 50-63 °C, 1 min; 72 °C for
1 min, for 35 cycles. The RT-PCR product was fractionated
by electrophoresis on a 1.4% agarose gel containing 1 µg/ml
ethidium bromide in 1X TAE buffer. Each membrane was also
hybridized with canine ACTB cDNA to normalize for RNA
loading, and image intensities of the blots were quantified using
a Bio-Imaging Analyzer-BAS 1000 (Fujifilm life Science,
Tokyo, Japan) and its associated software.
RESULTS
 We produced a custom-made microarray chip featuring about
4,500 retina-specific genes to investigate expression profiles
of the retina. First experiments evaluating reproducibility found
negligible variance between technical replicates (data not
shown). To allow cross-comparison between multiple condi-
tions, the experiment was arranged as reference design thus
allowing for an equal standardized error between each indi-
vidual comparison and avoiding dye bias. Therefore, each bio-
logical sample was hybridized only once. Given the differ-
ences in test and reference sample, different normalization
approaches were considered: block-specific loess normaliza-
tion (subgrid normalization), general loess normalization on
the entire array (global normalization), and subgrid loess nor-
malizations followed by either a MLE or MAD scaling proce-
dure (Appendix 1). This confirmed that the subgrid normal-
ization, as performed by GeneSpring, did not introduce data
bias, and was used for the presented results.
The canine retinal cDNA microarray was used to identify
genes preferentially expressed in normal 16-week-old retina
in comparison to a pooled brain reference sample. Quantita-
tive differences in the level of gene expression are illustrated
in a scatter plot (Figure 1) comparing the expression level for
normal retina (X-axis) versus the expression level from the
brain pool (Y-axis). High abundance of tissue-specific tran-
scripts is observed in spots located outside the two-fold ex-
pression lines (Figure 1, lines 2 and 3). SAM was used with a
FDR of 10%, to confirm that 13.2% of 3,070 valid genes
strongly hybridized to retinal cDNA targets, implying that 405
genes on the microarray are preferentially expressed in the
normal retina (Table 1, Appendix 1). Of the remainder, 2,213
transcripts showed equal expression between normal retina
and the brain pool reference tissue, and 14.7%, 452 genes,
were less abundant in the retina (Table 2). Note that we call
the spotted DNA sequences “genes” whether they correspond
to actual genes or ESTs.
To further characterize the genes found to be preferen-
tially expressed in brain, we hybridized the same brain pool
against cortex of frontal, occipital, and temporal brain regions
of three the different animals. Three percent of 3,489 valid
transcripts hybridized preferentially with the frontal region;
this corresponds to 114 genes highly expressed in the frontal
cortex. The occipital and temporal regions, respectively, had
22 and 20 genes (of 2,089 and 2,289 valid transcripts, respec-
tively) that were more abundant. Most transcripts were unique
to a single cortex area (Figure 2A, Table 3), and only two
genes were upregulated in all three brain regions
(DR010012A10F04, TM4SF1). Transcripts less abundant than
in the pooled reference also demonstrated a low overlap be-
tween brain regions (Figure 2B, Table 4), with one gene
downregulated in all three brain cortex areas (FLJ10159).
The obtained expression profiles were analyzed using PCA
revealing independent clustering of experiments derived from
retinal and brain samples (Figure 3). The PCA profile demon-
strates that a specific normal retinal gene expression profile
differs from the expression profiles of the frontal, occipital,
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TABLE 1. FUNCTIONAL ANNOTATION OF THE TOP 30 RETINA-ENRICHED GENES
                 GenBank
    Clone         access                                Gene     Gene ID      Human                             Retina/brain
  identifier      number     Dog chromosome location   symbol    number     chromosome          Unigene         fold change              Function
--------------   --------   ------------------------   -------   -------   -------------   ------------------   ------------   ----------------------------
DR010009B10H06   DT538190   25:47,884,218-47,884,349   SAG       6295      2q37.1          Hs.308 Cfa.7077         37          Rhodopsin-mediated signaling
DR010020A20B07   DT540322   14:21,958,280-21,958,543   GNAT1     2779      7q12.3          Hs.648519 Cfa.3191      36.5        Transport, visual system
DR010017A21C10   DT539700   7:22,113,973-22,114,385    PDC       5132      1q31.1          Hs.580 Cfa.1202         36          Signal, visual system
DR010018A20D11   DT539956   15:54,570,842-54,571,430   SFRP2     6423      4q31.3          Hs.481022               31.5        Unknown
DR010017A21D08   DT539707   20:8,475,328-8,475,483     RHO       6010      3q21-q24        Hs.247565 Cfa.7396      27.5        Signal, visual system
DR010024A10D06   DT541291   11:9,365,437-9,365,294                         9q32            Hs.150406               26          EST
DR010013B10A12   DT538991   3:94,958,572-9,958,849     PDE6B     399653    10p14           Hs.59872 Cfa.3793       25          Signal, visual system
DR010015B10D11   DT539417   18:64,384,884-64,385,136   ROM1      6094      11q12.3         Hs.281564               24.5        Disk morphogenesis
DR010030A20H09   DT543034   4:35,677,194-35,677,735                        10q23.1                                 23          EST
DR010008B20F12   DT538002   20:53,894,125-53,894,570   RDH8      50700     19p13.2         Hs.272405               21          Transport, visual system
DR010023B10C07   DT541135   17:37,457,058-37,457,430   DUSP2     1844      2q11.2          Hs.1183                 20.5        Nucleic acid metabolism
DR010022A20E08   DT540832   12:51,422,323-51,422,562                       6q15            Hs.520287               16          EST
DR010018B20H08   DT540046   2:87,515,835-87,515,994                        1p36.22         Hs.439194               11          EST
DR010008B20G12   DT538006   7:69,939,004-69,939,305    CLUL1     27098     18p11.32        Hs.274959 Cfa.3516       9.30       Unknown
DR010028B20H07   DT542573   27:4,960,724-4,961,087     NEUROD4   58158     12q13.2         Hs.131010                9.5        Metabolism
DR010028B10E10   DT542509   17:51,086,234-51,086,428   NLR       4901      14q11.1-q11.2   Hs.89606                 9          DNA, visual system
DR010029A10E09   DT542612   6:19,524,381-19,524,521    KCTD13    253980    16p11.2         Hs.534590                9          DNA metabolism
DR010009B10A10   DT538119   28:32,984,199-32,984,621   INPP5F    22876     10q26.12        Hs.369755                6.5        Metabolism
DR010022B20B07   DT540940   8:35,335,208-35,335,594    OTX2      5015      14q21-q22       Hs.288655                6          Metabolism
DR010021B20E07   DT540724   20:38,082,009-38,082,300   LRTM1     57408     3p14.3          Hs.554867                6          Sensory organ development
DR010019B20C09   DT540148   14:58,294,157-58,294,685                       7q31.2          Hs.239676                5          EST
DR010014B20E10   DT539271   5:37,315,043-37,315,421                        6p21.1                                   5          EST
DR010011A20D01   DT538558   18:9,132,499-9,132,941     ECOP      81552     7p11.2          Hs.488307                4.5        Signal transducer activity
DR010005B10H02   DT537179   5:59,339,081-59,339,539    GNB1      2782      1p36.33         Hs.430425                4.50       Signal transducer activity
DR010016B20C07   DT539561   2:74,241,431-74,241,808    HMG-17    403686    13p25.1         Hs.477784 Cfa.3549       4          Nucleic acid
DR010024B10C12   DT541427   22:7,990,538-7,990,876     HMGN2     3151      1p36.11         Hs.181163                4          Nucleic acid
DR010017B10E11   DT539798   23:35,612,629-35,613,006                       11q12.3         Hs.BC041359              4          EST
DR010027B20E09   DT542265   12:67,236,366-67,236,647   GLTP      51228     12q24.11        Hs.381256                4          Transport
DR010006B20G02   DT537497   2:78,953,814-78,954,066    DDOST     1650      1p36.12         Cfa.3884                 3.5        Metabolism
DR010029B10D10   DT542720   26:11,674,727-11,675,099   PPP1CC    5501      12q24.11        Hs.79081 Cfa.451         3.5        Metabolism
DR010007A10G09   DT537586   33:26,792,981-26,793,197                       3q13.33         Hs.333358                3.5        EST
The top 30 genes with preferential retinal expression in a retina-brain pool comparisons are listed, with the corresponding identifiers, chromo-
somal location, expression ratio, and function. Hs represents Homo sapiens, Cfa represents Canis familiaris.
Figure 1. MA-plot compar-
ing gene expression in retina
and brain reference pool.
Each point represents a
single transcript/spot on the
array, plotted as a function
of its signal amplitude (ex-
pression level) for brain pool
and retina. Line 1 denotes
equivalent expression in
retina and brain, whereas
lines 2 and 3 indicate a two-
fold difference in the signal
strength. For illustration,
spots representing Rhodop-
sin, much more abundant in
retina than brain, are located
within the red circle, while
the uniformly expressed β-
Actin spots lie within the
blue circle.
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and temporal cortices of the brain, while these clusters are
closely related. Within groups, experiments showed little varia-
tion, and the retinal profiles did not significantly differ with
regard to litter or sex of the tested individuals. The brain lobe
regions showed tissue-specific expression patterns, but one
temporal sample was clearly separated. The result was con-
firmed by independent replication of the experiment and could
represent an individual variation in this particular sample or
an experimental artifact.
To confirm the microarray results, we selected five genes
for northern analysis based on their microarray expression pro-
files. Two showed preferential expression in retina
(NEUROD4, DR010030A20H09), two in brain (SYN2, SPP1),
and one was equally expressed in retina and brain
(DR010024A20G01). Blots of total RNA from retina, brain,
and spleen were hybridized with cDNA probes for these five
genes (Appendix 1). We found that the northern blots showed
the same expression patterns predicted by the microarray data
with no detectable signal in spleen for any of the five genes
(Figure 4A). Semiquantitative determination of expression in
the northern blots correlated closely with the signal pattern
obtained from the microarray experiments (Figure 4B).
DISCUSSION
 We have undertaken the first step in the evaluation of the nor-
mal canine retinal expression profile to create a system that
©2006 Molecular VisionMolecular Vision 2006; 12:1048-56 <http://www.molvis.org/molvis/v12/a118/>
TABLE 2. FUNCTIONAL ANNOTATION OF THE 30 TOP BRAIN ENRICHED GENES
                 GenBank
    Clone         access                                   Gene      Gene ID     Human                            Retina/brain
  identifier      number     Dog chromosome location      symbol     number    chromosome         Unigene         fold change                  Function
--------------   --------   --------------------------   ---------   -------   ----------   -------------------   ------------   ------------------------------------
DR010023A20H05   DT541102   X:80,243,963-80,244,545      PLP1         5354      Xq22.2      Hs.1787 Cfa.3274         -25         Myelination
DR010027A10F10   DT542045   4:14,326,600-14,327,069      SPP1         6696      4q22.1      Hs.313                   -20         Phosphoprotein
DR010005A20E04   DT537067   32:13,862,656-13,862,983     SPARCL1      8404      4q22.1      Hs.1424                  -17         Extracellular matrix protein
DR010008A20A02   DT537874   20:40,129,412-40,129,709     NISCH        11188     3p21.1      Hs.435290                -16         Cytoskeleton and cellular components
DR010010B10C05   DT538398   6:62,422,039-62,422,316      LMO4         8543      1p22.3      Hs.436792                -11         Transcriptional regulator
DP010005000E06   DT536078   20:9,218,236-9,413,008       SYN2         6854      3p25        Hs.445503                 -9         Neuronal phosphoproteins
DR010027B20A04   DT542218   16:55,443,443-55,443,919     GPM6A        2823      4q34.2      Hs.75819                  -8         Myelin proteolipid
DR010014B20F03   DT539277   13:30,167,584-30,167,884     DDEF1        50807     8q24.21     Hs.106015 Cfa.10191       -6.5       Signal transduction
DR010015A20E10   DT539376   35:9,024,760-9,025,290       NRN1         51299     6p25.1      Hs.103291                 -6.5       Neural activity
DR010019A20H03   DT540130   24:15,030,049-15,043,202     SNAP25       6616      2p12.2      Hs.167317                 -6.5       Synaptic activity
DR010024A10E09   DT541302   26:31,587,239-31,587,700     SEPT5        5413      22q11.21    Hs.283743                 -6         Nucleic acids acitivity
DR010024B10F05   DT541444   4:69,817,413-69,817,666                             1q43                                  -6         EST
DR010026A20H08   DT541827   X:57,663,647-57,664,138      GDPD2        54857     Xq13.1      Hs.433812                 -5         Cell differentiation
DR010013A10A11   DT538911   13:52,260,613-52,260,773     IGFBP7       3490      4q12        Hs.479808                 -5         Insulin-like growth factor
DR010022A10B01   DT540751   24:15,694,097-15,694,559     C20orf103    24141     20p12.2     Hs.22920                  -4.4       Protein precursor
DR010020A10B08   DT540252   17:62,843,281-62,843,815     MLLT11       10962     1q21.2      Hs.75823                  -4.2       leukemogenesis
DR010025B10A02   DT541635   X:43,640,390-43,640,656                             10q23.33                              -4         Unknown
DR010026B20G05   DT541971   5:39,939,020-39,939,274                             17p12                                 -4         Unknown
DR010025A21C11   DT541582   26:3,428,348-3,428,585       PXMP2        5827      12q24.33    Hs.430299                 -3.6       Nucleic acitvity
DR010015A20E09   DT539375   15:5,881,332-5,881,851       PPT1         5538      1p34.2      Hs.3873 Cfa.10158         -3.6       Metabolism
DR010016B10H12   DT539539   20:48,103,437-48,103,712                            19p13.11                              -3         EST
DR010005B10E03   DT537156   2:79,096,079-79,096,475      CAMK2N1      55450     1p36.12     Hs.197922                 -3         Metabolism
DR010012B20D10   DT539065   24:35,260,072-35,260,236     YWHAB        7529      20p13.12    Hs.279920                 -2.5       Signal transduction
DR010020A20D02   DT540337   1:98,778,726-98,779,224      DIRAS2       54769     9q22.2      Hs.165636                 -2.5       Metabolism
DR010024A20H05   DT541397   10:52,558,495-52,558,873     CALM2        805       2p21        Hs.468442                 -2.5       Metabolism
DR010010A20G08   DT538371   1:111,515,746-111,516,031    CALM3        808       19q13.32    Hs.515487                 -2.5       Metabolism
DR010013B10A11   DT538990   4:12,791,804-12,792,189                             3p21.31                               -2.5       EST
DR010013A10E12   DT539022   3:32,111,666-32,111,915                             15q22.2                               -2.5       EST
DR010028A20D02   DT542393   16:22,581,974-22,582,397                            15q14                                 -2.5       EST
DR010012B20E05   DT538877   11,386,498-11,386,885        ATP2A2       488       12q24.11    Hs.506759                 -2.5       Metabolism
The top 30 genes with preferential brain expression in a retina-brain pool comparison are listed, with the corresponding identifiers, chromo-
somal location, expression ratio, and function. Hs represents Homo sapiens, Cfa represents Canis familiaris.
Figure 2. Region-dependent
expression pattern for frontal,
occipital, and temporal brain
cortices.  The diagrams show
the number of genes up- (A)
and downregulated (B) in the
respective regions.
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allows comparison within and between different models of
retinal degeneration. For this purpose, a reference design was
chosen, which, ideally, would utilize a pool of normal retina
as reference. It is not possible, however, to provide a retina
pool that is large enough for the proposed scale of experi-
ments, and, therefore, was substituted by a brain pool. The
limitation of this reference is that genes not expressed in the
brain cannot be validated against this common reference, and
common data analysis procedures, such as normalization,
might introduce experimental errors based on the tissue-spe-
cific differences. This study has validated the procedure, and
identified potential problematic genes which subsequently can
be investigated in alternate approaches such as quantitative
RT-PCR or macroarrays [26] that selectively target for analy-
sis those genes not expressed in the brain pool.
Microarray data are most commonly normalized using
the loess algorithm, which assumes that only a small percent-
age of genes is differentially expressed, and maintains bal-
ance between the numbers of up- and downregulated expressed
transcripts. Alternative approaches for normalization proce-
dures propose the use of ANOVA models [27]. This method
essentially performs only a global normalization, and does not
correct for intensity or scale differences. Yang et al. [24] have
found that the standard global median normalization can of-
ten be inadequate due to spatial and intensity dependent dye
biases, and proposed loess subgrid normalization. We have
applied different models to our data (Appendix 1), which fur-
ther support these findings and suggests that we do not intro-
duce experimental bias in the data by applying the loess subgrid
normalization.
As an initial step in evaluating the microarray, we exam-
ined gene expression pattern differences between normal retina
and the brain pool tissue reference sample. These compari-
sons allowed us to identify 405 out of 3,070 valid transcripts
(13.2%) as preferentially expressed in retina (Table 1), and
452 genes with low abundance in the retina (Table 2). As ex-
pected, known photoreceptor genes were highly expressed in
retina, demonstrating the specificity of the hybridization. Over
a third of the differentially expressed clones represent poten-
tially novel genes that are enriched or even specific to retina
or brain [28]. Among the differential expressed genes were
many important to neural activity, such as ion channels (trans-
port class) and cytoskeletal proteins (structural class). Genes
involved in more general processes, such as energy genera-
tion, also showed retina or brain preferred expression. Com-
pared to the total number of genes with preferential expres-
sion, we found higher frequencies of proliferation and cell
death genes expressed in the brain than retina, and nucleic
acid processing genes in retina than brain. Among the tran-
scripts preferentially expressed in the brain were many known
and unknown genes not previously reported to have a prefer-
ential expression pattern in different regions of the brain [5,29].
We demonstrated also that expression patterns are quite re-
stricted to individual cortex areas, as few differential expressed
genes showed overlap between the examined brain regions
(Figure 2).
It is clear that, despite the common embryonic origin of
retina and brain tissues, the corresponding expression profiles
differ. Even though a subset of the genes expressed in each of
the three brain regions were unique to the tissue of origin, this
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TABLE 3. GENES UPREGULATED AND EXPRESSED IN TWO OR THREE BRAIN CORTICES
                 GenBank
    Clone         access                                  Gene     Gene ID     Human                            Overlapping
  identifier      number     Dog chromosome location     symbol    number    chromosome         Unigene           regions            Function
--------------   --------   -------------------------   --------   -------   ----------   -------------------   -----------   -----------------------
DR010026A10E12   DT541032   1:75,209,657-75,209,810     C1orf63     57035     1p36.11     Hs.259412 Cfa.10157      F-O        Open reading frame
DR010027A10B02   DT541999   9:7,065,312-7,065,859                             17q24.2                              F-O        EST
DR010023B10A04   DT541111   22:64,149,260-64,149,794    UPF3A       65110     13q34       Hs.533855                F-T        Metabolism
DR010019B10C12   DT540150   12:7,009,358-7,009,914                            6p21.31                              F-T        EST
DR010017A10B01   DT539606   8:50,712,025-50,712,500     KIAA0317    9870      14q24.3     Hs.497417                F-T        Unknown
DR010018B10B12   DT539606   27:40,457,438-40,457,926    NECAP1      25977     12p13.31    Hs.555927                F-T        Involved in endocytosis
DR010023B10B01   DT541120   18:59,559,359-59,559,613                          7q21.3                               O-T        EST
DR010012B10B11   DT541128   10:14,366,170-14,366,540    CPSF6       11052     12q15       Hs.369606                O-T        Nucleic acids
DR010010B20H09   DT538497   7:12,476,293-12,476,485                           14q23.1                              O-T        EST
DR010012A10F04   DT538700   9:11,033,436-11,033,709                           11q13.1                              F-O-T      EST
DR010009B20B10   DT538214   23:47,202,203-47,202,727    TM4SF1      4071      3q25.1      Hs.351316                F-O-T      Metabolism
Hs represents Homo sapiens, Cfa represents Canis familiaris, F represents Frontal, O represents Occipital, T represents Temporal.
TABLE 4. GENES DOWNREGULATED AND EXPRESSED IN TWO OR THREE BRAIN CORTICES
Hs represents Homo sapiens; Cfa represents Canis familiaris; F represents frontal; T represents temporal; O represents occipital.
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Figure 3. Principal component
analysis illustrates differentia-
tion of retinal gene expression
profile from the three brain re-
gions.  No variance is found
between individuals from dif-
ferent litters (experiment 1
[Exp.1] versus experiment 2
[Exp. 2]) or between males
(squares) and females (circles).
Figure 4. Northern blot valida-
tion of selected genes.  A: Ex-
pression profile for selected
genes was obtained from
northern analysis using brain
(B), retina (R), and spleen (S)
through normalization against
the canine β-actin loading con-
trol, and compared to
microarray results (B).
NEUROD4: neurogenic differ-
entiation 4; SYN2: synapsin II;
SPP1: secreted phosphopro-
tein 1.
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was proportionately a small part of the total number of genes
examined. Overall, the gene expression profiles of the three
brain regions clustered closely, when compared to the differ-
ent profile obtained from retina (Figure 3). The PCA also il-
lustrates strong similarities in each of the replicates for a given
tissue, showing the sensitivity and robustness of the custom
cDNA microarray. Particularly for the retina, we did not ob-
serve significant differences in expression profiles between
16 week old dogs based on gender or litter as has previously
been suggested from human studies [14].
Results of the microarray work were validated on north-
ern analysis for individual transcripts (Figure 4) and confirmed
to reflect the physiology of the analyzed tissues. For example,
we found that NEUROD4 had an increased expression level
in retina compared to brain according with its function in the
developing mammalian retina [30]. CDKN1B was equally
expressed in normal retina and brain tissues; this gene encodes
a protein that binds to and prevents the activation of cyclin E-
CDK2 or cyclin D-CDK4 complexes, and thus controls the
cell cycle progression at G1. The microarray results also iden-
tified ESTs representing potential novel genes that showed
high preferential levels of expression in retina (e.g.,
DR010020A10D06, DR10030A20H09; Table 1). These novel
genes of still unknown function are currently under further
investigation as they may play critical roles in retinal devel-
opment or maintenance, and are potential candidate genes for
retinal disorders.
Recent expression studies conducted for human retina uti-
lized the comparisons to different tissues, such as brain, liver,
or kidney across SAGE, cDNA library, and microarray plat-
forms [31,32]. In each case, the results yielding a few hun-
dred retina-enriched genes can be classified into three differ-
ent types: 1-genes already known to be retina enriched, such
as guanine nucleotide binding protein (GNAT1) and arrestin
(ARR3); 2-characterized genes previously not known to be
retina enriched, such as WNT inhibitory factor 1 (WIF1) and
frizzled-related protein (FRZB), and 3-unknown genes, mostly
EST clusters. Our data are not just comparable to those stud-
ies in terms of identified classes and the ratio of genes spe-
cific to the retina, but provide additional information for po-
tential novel genes integrated in the original EST database
that allows the subsequent characterization of these transcripts
[16].
It has been suggested that genes involved in developmental
regulation of the retina are among the top candidates for de-
generative processes when mutated. Recently, a microarray
profile between wild type and Nrl-/- mouse retinas produced a
list of 1,000 genes with potential high influence in rod devel-
opment [33]. Among those were several genes associated with
human retinopathies (e.g., GNAT1, RHO, SAG, ROM1,
PDE6B) that have also been identified through our analysis
(Table 1, Appendix 1). Furthermore, this work presents com-
parable percentage of genes involved in metabolic pathways
and unknown genes, suggesting that our microarray results
are a suitable model system to address retina-specific biologi-
cal questions. The results can now be extended to examine the
gene expression profiles of different canine retinal degenera-
tion models aiming to differentiate those pathways that are
unique and mutation-specific from those that are mutation-
independent and common to several of the retinal disorders.
This approach will provide new insights into the molecular
mechanisms of these diseases, and help identify key molecules
and pathways for therapeutic intervention.
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